Allergen-induced dermatitis causes alterations in cutaneous retinoid-mediated signaling in mice by Gericke, Janine et al.
Allergen-Induced Dermatitis Causes Alterations in
Cutaneous Retinoid-Mediated Signaling in Mice
Janine Gericke1, Jan Ittensohn1, Johanna Miha´ly1,2, Sandrine Dubrac3, Ralph Ru¨hl1,2,4*
1 Laboratory of Nutritional Bioactivation and Bioanalysis, Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary, 2 Paprika
Bioanalytics BT, Debrecen, Hungary, 3 Epidermal Biology Laboratory, Department of Dermatology, Innsbruck Medical University, Innsbruck, Austria, 4Apoptosis and
Genomics Research Group of the Hungarian Academy of Science, Debrecen, Hungary
Abstract
Nuclear receptor-mediated signaling via RARs and PPARd is involved in the regulation of skin homeostasis. Moreover,
activation of both RAR and PPARd was shown to alter skin inflammation. Endogenous all-trans retinoic acid (ATRA) can
activate both receptors depending on specific transport proteins: Fabp5 initiates PPARd signaling whereas Crabp2
promotes RAR signaling. Repetitive topical applications of ovalbumin (OVA) in combination with intraperitoneal injections
of OVA or only intraperitoneal OVA applications were used to induce allergic dermatitis. In our mouse model, expression of
IL-4, and Hbegf increased whereas expression of involucrin, Abca12 and Spink5 decreased in inflamed skin, demonstrating
altered immune response and epidermal barrier homeostasis. Comprehensive gene expression analysis showed alterations
of the cutaneous retinoid metabolism and retinoid-mediated signaling in allergic skin immune response. Notably, ATRA
synthesis was increased as indicated by the elevated expression of retinaldehyde dehydrogenases and increased levels of
ATRA. Consequently, the expression pattern of genes downstream to RAR was altered. Furthermore, the increased ratio of
Fabp5 vs. Crabp2 may indicate an up-regulation of the PPARd pathway in allergen-induced dermatitis in addition to the
altered RAR signaling. Thus, our findings suggest that ATRA levels, RAR-mediated signaling and signaling involved in PPARd
pathways are mainly increased in allergen-induced dermatitis and may contribute to the development and/or maintenance
of allergic skin diseases.
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Introduction
Atopic dermatitis (AD) is the most common inflammatory skin
condition, predominantly affecting infants and children and
characterized by pruritus, eczematous lesions, and skin dryness.
Furthermore, the disease is commonly associated with allergic
conditions such as allergic rhinitis and asthma. AD affects 10–30%
of children and 2–10% of adults in industrialized countries, with a
marked increase in AD prevalence during the past 30 years [1–3].
While various studies reported an ‘‘outside-inside-outside’’ path-
ogenic mechanism of AD [4–6], its exact pathogenesis is not yet
fully elucidated.
Vitamin A and its derivatives, the retinoids, are essential for skin
physiology [7] through their role in the regulation of several
aspects of skin cell proliferation, differentiation, apoptosis, immune
regulation and epidermal barrier function [8,9]. Noticeably,
alterations of retinoid metabolism and signaling were found in
skin of patients with various skin diseases, such as psoriasis [10],
ichthyosis [11], and recently by our group in AD [12]. Thereby, it
is unclear whether these alterations are the trigger or if they are
consequence of these skin diseases. Furthermore, it was previously
shown that retinoids are able to modify the immune phenotype of
atopic diseases such as AD [13,14].
Retinoids mediate their function mainly via signaling through
nuclear hormone receptors, i.e. retinoic acid receptor (RAR) a, b,
and c and retinoid X receptor (RXR) a, b, and c. RARs and other
nuclear receptors, like peroxisome proliferator-activated receptors
(PPAR) a, d (b), and c, function as ligand-dependent transcription
factors and regulate the expression of various genes after
heterodimerization with RXR [15]. Within these three receptor
families, RARc, RXRa and PPARd are the most abundant
subtypes present in skin [16,17].
PPARmediated pathways are important in skin physiology
because they are involved in epidermal barrier recovery,
keratinocyte differentiation and lipid synthesis [16]. For example,
overexpression of PPARd in the epidermis causes a psoriasis-like
skin disease featuring hyperproliferation of keratinocytes, dendritic
cell accumulation, and endothelial activation [18]. Interestingly, a
cross-talk exists between RAR and PPARd pathways. Indeed,
RARc and PPARd can both be activated by the endogenous RAR
ligand all-trans retinoic acid (ATRA), depending on specific
transport proteins. The cellular retinoic acid binding protein 2
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(Crabp2) initiates RAR signaling, whereas the fatty acid-binding
protein 5 (Fabp5) promotes PPARd-mediated signaling after
ATRA-binding [19,20]. However, these findings are controver-
sially discussed in the literature [21–23]. Moreover, PPARd
activation has been reported at high ATRA concentrations
suggesting that tissue levels of ATRA can determine which
nuclear receptor pathways are up-regulated and thereby influence
the gene expression profile [19,20].
The aim of the present study was to determine whether the
induction of allergic immune responses in the skin by combined
systemic and topical treatments with ovalbumin (OVA) is able to
modify retinoid metabolism and retinoid-mediated signaling in the
skin of mice. Furthermore, we studied the effects of systemic OVA
sensitization without further topical sensitization on skin retinoid
metabolism as a potential model for an inside-outside patho-
mechanism of allergic skin disorders. Our final aim was to
determine via which nuclear hormone receptor-mediated path-
ways retinoid signaling might be regulated to modify skin
inflammation and homeostasis in allergen-induced dermatitis.
Materials and Methods
Sensitization of Mice
8–10 weeks old female BALB/c mice, were obtained from and
housed within the animal facility of the University of Debrecen,
Hungary. Animals were maintained in single cages with standard
animal chow and water ad libitum. All experimental procedures
were approved by the Committee of Animal Research of the
University of Debrecen, Hungary (Approval number: 25/2006
DEMA´B).
Sensitization of mice was performed by repetitive systemic
application of OVA and allergen-induced dermatitis based on a
model previously reported [24,25]. Briefly, mice were sensitized at
days 47, 60 and 67 with 10 mg OVA intraperitoneally (i.p.)
(Sigma-Aldrich, Budapest, Hungary) adsorbed to 1.5 mg alumi-
num hydroxide (Al(OH)3) (Thermoscientific, Budapest, H) or with
phosphate-buffered saline (PBS; control) (Figure 1a). For com-
bined treatment [24], mice were sensitized i.p. on days 1, 14 and
21 with 10 mg OVA adsorbed to 1.5 mg Al(OH)3. This was
followed by topical application of 100 mg OVA adsorbed to
1.5 mg Al(OH)3 in 100 ml PBS (weekly dose) onto shaved back
skin, divided into four applications of 25 ml every other day of one
week (Figure 1b). Epicutaneous (e.c.) treatment was repeated for a
total exposure of three weeks separated by two-week intervals.
Three days after the last treatment (day 70) mice were euthanized:
skin and serum samples were collected and kept at 280uC until
analyses.
Histological Analysis
Skin biopsies of were taken from similar body sites, fixed
overnight with 4% paraformaldehyde at 4uC, and embedded in
paraffin. Five-micrometer sections were stained with hematoxylin
and eosin (H&E) or Giemsa. Mast cells were quantified under a
light microscope using 20x lenses and a calibrated grid (six fields
per sample) while epidermal thickness was measured using 10x
lenses (five measurements per mouse).
Immunohistochemical Analysis
To quantitate lymphocytes and dendritic cells in the skin, CD3+,
CD4+, CD8+, MHC-class II+ and CD11c+ cells in frozen skin
sections were counted under an Olympus BX60 epifluorescence
microscope using 406 objective lenses and a calibrated grid (six
fields per section). For detailed information on used antibodies and
staining procedure refer to Materials and Methods S1a. After
fixation in paraformaldehyde, five-micrometer sections were
incubated with a rabbit anti-mouse Fabp5 polyclonal antibody
(1:50; ProteinTech, Chicago, IL) following manufacturer’s direc-
tions after antigen retrieval (Materials and Methods S1b).
Total IgE Levels in Serum
Sera were collected at day 70 of the experiment (Figure 1a and
b) and kept at280uC until analysis. Plasma IgE concentration was
measured using the mouse ELISA kit from BD-Pharmingen.
RNA Preparation and Reverse Transcription
Total RNA was isolated from frozen skin using TriH reagent
(Molecular Research Center Inc., Cincinnati, OH) following the
manufacturer’s instructions. 750 ng of total RNA were reverse
transcribed into cDNA in a 30 ml reaction using the High
Capacity cDNA Reverse Transcription Kit (Life Technologies,
Budapest, H) according to the manufacturer’s protocol.
Analysis of mRNA Expression
mRNA expression in skin was determined by means of
quantitative real time-PCR (qRT-PCR) and TaqManH Low
Density Arrays (TLDA) on an ABI Prism 7900. qRT-PCR
measurements were performed in triplicate using pre-designed
TaqManH Gene Expression Assays and reagents; TaqManH Low
Density Array cards were used for duplicate determinations using
TaqManH Gene Expression Master Mix (all Applied Biosystems
Applera Hungary, Budapest, H). Relative quantification of mRNA
expression was achieved using the comparative CT method and
values were normalized to cyclophilin A mRNA. Gene expression
values below detection limit were assumed to be zero for the
purpose of statistical analysis.
Determination of FABP5 Protein in Skin
FABP5 protein levels were determined in protein lysates
prepared from whole mouse skin according to the protocol
indicated in Materials and Methods S2 using the rabbit FABP5
polyclonal antibody purchased from ProteinTech (Chicago, IL).
Determination of Retinol and ATRA Levels in Skin
Concentrations of ATRA and retinol were determined in mouse
skin samples by our high performance liquid chromatography
mass spectrometry - mass spectrometry (HPLC MS-MS) method
as described in Materials and Methods S3 [26].
Cytokine Levels in Serum
Levels of TSLP, IL-4 and IL-12 (p70) were determined in serum
using Quantikine Mouse Immunoassays (R&D Systems, Abing-
don, UK), according to the manufacturer’s protocol. Assay
sensitivity was 2.63 pg/mL for TSLP, ,2 pg/mL for IL-4, and
,2.5 pg/mL for IL-12.
Statistical Analysis
Data are indicated as mean 6 SEM. Statistical analysis was
performed using one-way ANOVA followed by Tukey correction.
Significance of HPLC MS-MS results was determined using
Student’s t-test. Differences were considered significant at p,0.05.
Atopic Sensitization Disturbs Retinoid Signaling
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e71244
Results
Systemic Sensitization with OVA Induces Mild Allergen-
induced Dermatitis When Compared to Additional
Topical OVA Applications
BALB/c mice were systemically sensitized with OVA in
addition or not to topical sensitization onto shaved back skin
(Figure 1a and b) and compared with PBS-injected mice (controls).
Sensitization with OVA induced mild but statistically significant
focal hyperplasia with a two-fold (OVA i.p.; p,0.001 vs. PBS i.p.)
or three-fold (OVA i.p.+e.c.; p,0.001 vs. PBS i.p.; p,0.001 vs.
OVA i.p.) increase in epidermal thickness, respectively (Figure 1c).
Histological analysis further revealed scaly skin in both OVA-
sensitized groups (Figure 1c). Interestingly, repeated systemic
sensitization with OVA did not alter total serum IgE levels
compared to control mice (Figure 1d). However, combined
systemic and topical sensitization leading to allergen-induced
dermatitis resulted in significantly increased total serum IgE
(21.69661.655 ng/ml) when compared to controls and systemi-
cally sensitized mice (Figure 1d). Furthermore, inflammatory cells
infiltrating the skin were characterized by Giemsa staining and
immunohistochemical methods. Numbers of mast cells were
significantly elevated in the dermis of both OVA-sensitized
groups, while the increase in macrophages, dermal dendritic cells
and CD4+ lymphocytes reached statistical significance only in
allergen-induced dermatitis (Table 1). Sensitization with OVA
induced elevated numbers of CD3+ lymphocytes in both, the
dermis and epidermis (data not shown). Only few CD8+
lymphocytes could be detected in skin sections of OVA-sensitized
mice (data not shown). Eosinophils could only be found in the
dermis of OVA-sensitized mice and predominantly in allergen-
induced dermatitis (Table 1). In the epidermis, several Langerhans
cells exhibiting activated morphology could be observed in OVA-
sensitized mice (data not shown). Altogether, numbers of mast
cells, macrophages and dermal dendritic cells were significantly
higher only in allergen-induced dermatitis (Table 1). Thus,
repeated systemic sensitization with OVA is sufficient to initiate
an inflammatory immune response in the skin whereas additional
topical sensitization is required to induce full allergen-mediated
dermatitis in mice [24,25].
Expression of Th1- and Th2-type Immune Response
Genes is only Altered in Allergen-induced Dermatitis
Expression of genes relevant for Th1- or Th2-type immune
response was analyzed in the skin of mice by qRT-PCR and
TLDA. As shown in Table 2, gene expression levels of the
inflammation-associated keratin 17 (Krt17) was moderately
increased in the skin of OVA-sensitized mice. In contrast,
expression of Th1 related genes including interferon c (Ifng) and
interleukin 12A (Il12a) and of Th2 associated genes including
interleukin 4 (Il4), interleukin 10 (Il10), chemokine ligand 11
(eotaxin 1; Ccl11) and its corresponding chemokine receptor 3
(Ccr3) was significantly elevated only in the skin of mice with
allergen-induced dermatitis (Table 2). Altogether, these results
(Tables 1 and 2) show that only combined systemic and topical
Figure 1. Sensitization protocol, histological analysis, and IgE serum levels. (a) Mice were sensitized i.p. with 10 mg OVA adsorbed to
1.5 mg Al(OH)3 or with phosphate-buffered saline (PBS; control) on days 47, 60 and 67 (black arrows). (b) A third group of mice was sensitized i.p.
with 10 mg OVA adsorbed to 1.5 mg Al(OH)3 on days 1, 14 and 21 (black arrows) followed by e.c. OVA exposure for three 1-week periods (grey
arrows) separated by 2-weeks intervals. Each mouse received a weekly e.c. dose of 100 mg OVA adsorbed to 1.5 mg Al(OH)3 in 100 ml PBS on shaved
back skin divided into four applications of 25 ml every other day of one week (black angular arrows). Three days after the last treatment (day 70), mice
were sacrificed and skin and serum samples were collected. (c) Hematoxylin and Eosin staining of five-micrometer skin sections obtained from
treated dorsal skin sites. Images were taken at610 magnification (scale bar = 50 mm). (d) Total IgE levels were determined in the serum of mice
treated systemically with or without additional topical sensitization with OVA. Data are presented as mean values 6 SEM of three independent
measurements with triplicate determination of n = 8 mice/group. Statistical significance (p) is based on one-way ANOVA followed by Tukey’s multiple
comparison test.
doi:10.1371/journal.pone.0071244.g001
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sensitizations with OVA fully recapitulate allergen-induced
dermatitis symptoms, which are also found in chronic AD [27–31].
Systemic Sensitization with OVA is Sufficient to Modify
Expression of Genes Involved in Epidermal Barrier
Homeostasis
Decreased expression of genes related to the epidermal
protein compartment. mRNA levels of several genes involved
in epidermal barrier formation and maintenance, such as
keratinocyte differentiation markers involucrin (Ivl) and loricrin
(Lor), matrix metalloproteinase 9 (Mmp9) and serine peptidase
inhibitor Kazal-type 5 (Spink5) were significantly decreased in the
skin of OVAtreated mice (Table 2). Notably, expression levels of
all tested genes, except for psoriasin, were lower in the OVA-
treated mice (Table 2). Indeed, psoriasin (S100a7a) expression was
induced in mice treated with OVA (Table 2).
Increased expression of genes related to the epidermal
lipid compartment. In contrast to the protein compartment,
genes related to the epidermal lipid compartment were mainly up-
regulated in mouse skin after OVA challenges. In fact, mRNA
expression levels of 3-Hydroxy-3-methylglutaryl-CoA synthase 2
(Hmgcs2), involved in cholesterol synthesis, of serine palmitoyl-
transferase 2 (Sptlc2), UDP-glucose ceramide glucosyltransferase
(Ugcg), both catalyzing the synthesis of ceramides and glycosyl-
ceramides, and of alkaline ceramidase 1 (Acer1), which is
responsible for ceramide degradation, were significantly elevated
in the skin of mice with allergen-induced dermatitis and/or solely
systemic OVA sensitization (Table 2). Noticeably, only expression
of ATP-binding cassette A12 (Abca12), which is responsible for
lipid loading into lamellar bodies, was decreased in OVA-treated
groups (Table 2). Taken together, our results suggest that systemic
sensitization with OVA is sufficient to decrease expression of
differentiation markers and to increase expression of proteins
involved in the cutaneous lipid metabolism. This, in turn, might
lead to an impaired epidermal barrier function.
Systemic Sensitization with OVA Triggers IL-4 Serum
Levels
Levels of the cytokines IL-4, TSLP and IL-12 (IL-12p70) were
determined in the sera of OVA-sensitized and control mice. IL-4
but not TSLP was significantly increased in both OVA-treated
groups (Table 1, Figure 2a). Serum levels of IL-12, a Th1-type
cytokine, remained similar in all groups (Table 1).
Retinoic Acid Levels and Retinoid Metabolism are
Increased in Allergen-induced Dermatitis
While retinoid-mediated signaling in skin is involved in several
physiological processes, little is known about RAR-mediated
signaling in inflammatory skin diseases [12]. By means of our
mouse model we aimed to investigate whether repeated systemic
and combined systemic and topical sensitizations with OVA are
able to induce changes in retinoid metabolism and retinoid-
mediated signaling on the gene expression level in skin. After
sensitization, expression of short chain dehydrogenase/reductase
16C5 (Sdr16c5), responsible for the oxidation of retinol to retinal,
was induced compared to controls while expression of retinol
dehydrogenase 10 (Rdh10) remained unchanged (Table 3). In
contrast, expression of enzymes responsible for the conversion of
retinal to the bioactive vitamin A derivative ATRA (aldehyde
dehydrogenases; Aldh1a1, 1a2, and 1a3) was significantly
increased only in allergen-induced dermatitis (Table 3). Impor-
tantly, we found significantly elevated concentrations of ATRA
only in the skin of mice with allergen-induced dermatitis
(Figure 2b, Table S1), while retinol levels remained unchanged
(Table S1). Different retinoid receptors mediate the effects of
ATRA in skin. Parallel to ATRA skin content, elevated mRNA
levels of RARc and RXRa, both the most abundant retinoid
receptors in skin, were evidenced only in allergen-induced
dermatitis (Table 3). To further investigate the induction of
retinoid-mediated signaling in sensitized skin, we next assessed
expression of RAR target genes. Accordingly, we found that
expression of genes encoding RA degradation enzymes, cyto-
chrome P450 26a1 (Cyp26a1; eight-fold induction) and Cyp26b1
(two-fold increase) was increased in allergen-induced dermatitis
(Table 3). Expression of proteins involved in retinoid transport
(Rbp1, Crabp2) and metabolism (Lrat) was similarly increased in
the skin of mice treated with OVA, regardless of further topical
sensitization with OVA, whereas expression of RAR target genes
not involved in retinoid signaling (Krt4, Rarres2, Tgm2) was not
significantly altered (Table 3). Notably, the ratio of Fabp5 vs.
Crabp2 gene expression, both delivering ATRA to their respective
cognate receptors, significantly increased in allergen-induced
dermatitis (Figure 2c). Thus, allergen-induced dermatitis might
lead to increased ATRA levels in the skin and dysregulated
Table 1. Systemic sensitization with ovalbumin (OVA)
induced mild allergic dermatitis when compared to additional
topical OVA applications.
Sensitization
Analysis PBS i.p. OVA i.p.
OVA
i.p.+e.c.
Inflammatory cell infiltrate in skin1
Mast cells2 761 2762*** 4563***###
Eosinophils2 060 561* 962***
Macrophages (MHC II+CD11c2)3 307616 369621 474614***##
Dermal dendritic cells (MHC
II+CD11c+)3
4063 5964 90610***#
CD3+ lymphocytes3 164613 240615** 285610***
CD4+ lymphocytes3 461 1162 1462**
Cytokine serum levels (pg/mL)4
Th1-type
Interleukin 12 p70 (IL-12) 7.463.9 6.564 8.465.6
Th2-type
Interleukin 4 (IL-4) 73622 179624* 198615**
Thymic stromal lymphopoietin
(Tslp)
3.560.5 3.761.2 3.460.4
e.c., epicutaneous; i.p., intraperitoneal; OVA, ovalbumin; PBS, phosphate-
buffered saline; Th, T-helper cell.
Data are indicated as mean 6 SEM. Statistical significance (p) was tested using
one-way ANOVA followed by Tukey’s multiple comparison test.
*p,0.05,
**p,0.01,
***p,0.001, versus PBS i.p.;
#p,0.05,
##p,0.01, and ###p,0.001, versus OVA i.p.
1Positively stained cells were counted in six fields per section of n = 5 (IHC-
staining) or n = 8 animals (Giemsa-staining), respectively, and expressed as cells
per mm2.
2Determined in Giemsa-stained skin sections.
3Determined in IHC-stained skin sections.
4Cytokine levels in sera were determined as triplicate measurements of
n = 4 mice per group using Quantikine mouse immunoassay kits. Data are
indicated as pg/ml.
doi:10.1371/journal.pone.0071244.t001
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retinoid metabolism and signaling at least in our mouse model of
the disease.
Gene Targets Involved in and Mediated by PPARd
Pathways in Skin are Mainly Up-regulated in Allergen-
induced Dermatitis
Gene expression of PPARd as well as several of its target genes
in skin is presented in Table 2. Systemic or systemic plus topical
sensitization of mice with OVA led to reduced PPARd gene
expression compared to controls and this decrease was somewhat
more pronounced in mice systemically sensitized only. In contrast,
mRNA expression of Fabp5, the fatty acid binding protein which
delivers ligands to PPARd, was increased after sensitization with
OVA (Table 2). Moreover, keratin 6b (Krt6b), keratin 16 (Krt16),
heparin-binding EGF-like growth factor (Hbegf) and Hmgcs2, all
of which known to be induced upon PPARd activation and
involved in epidermal barrier homeostasis [18,32,33], showed
significantly elevated gene expression levels in skin after systemic
and topical sensitization. Only the PPARd target gene Abca12
[34], which is responsible for epidermal barrier formation and
maintenance, showed decreased mRNA levels in both OVA
treatment groups (Table 2). Altogether, our results suggest an
induction of gene targets which are involved in PPARd signaling
Table 2. Systemic and topical OVA sensitization results in inflammation, disturbs epidermal barrier homeostasis, and induces
PPARd target gene expression in skin.
Fold change
Gene name Symbol OVA i.p. OVA i.p.+e.c.
Immune response
Keratin 17 Krt17 1.660.2* 1.760.2**
Th1-type
Interleukin 12A Il12a 16396719 26136740*
Interferon c Ifng 11.165.4 22.162.8**
Th2-type
Interleukin 4 Il4 11.764.5 92.7630.9**#
Interleukin 10 Il10 12.465.5 32.7613.1*
Chemokine (CC motif) ligand 11/eotaxin 1 Ccl11 0.260.2 13.865.1*#
Chemokine (CC motif) receptor 3 Ccr3 63.7634.4 17636534***##
Epidermal barrier homeostasis
ATP-binding cassette A121 Abca12 0.360*** 0.660.1***##
Involucrin Ivl 0.660.1* 0.460***
Loricrin Lor 0.560* 0.860.1#
Serine peptidase inhibitor, Kazal-type 5 Spink5 0.260*** 0.460***
Matrix metalloproteinase 9 Mmp9 0.160*** 0.660.1##
S100 calcium binding protein A7A/psoriasin S100a7a 2.660.3** 2.160.3*
3-Hydroxy-3-methylglutaryl-CoA synthase 21 Hmgcs2 0.460.1 4.461.1**##
Serine palmitoyltransferase long chain base subunit 2 Sptlc2 1.260.3 33.8610.6**##
UDP-glucose ceramide glucosyltransferase Ugcg 196616.9*** 161614.4***
Alkaline ceramidase 1 Acer1 2.260.6 3.960.3***#
PPARd signaling
Peroxisome proliferator-activated receptor d Ppard 0.460** 0.660*
Fatty acid-binding protein 5 Fabp5 1.760.3 2.260.2**
ATP-binding cassette A121 Abca12 0.360*** 0.660.1***##
Keratin 6B Krt6b 5.860.6 6326177**##
Keratin 16 Krt16 0.560 5.761.2***###
Heparin-binding EGF-like growth factor Hbegf 1.160.1 2.160.3*#
3-Hydroxy-3-methylglutaryl-CoA synthase 21 Hmgcs2 0.460.1 4.461.1**##
e.c., epicutaneous; i.p., intraperitoneal; OVA, ovalbumin; Th, T-helper cell.
1Enumerated twice because the gene is relevant for two pathways.
Fold change data are expressed as mean 6 SEM (n = 6) and were determined in skin specimen of sensitized mice by TLDA or qRT-PCR. Statistical significance (p) was
tested using one-way ANOVA followed by Tukey’s multiple comparison test.
*p,0.05,
**p,0.01,
***p,0.001, versus control (PBS i.p.);
#p,0.05,
##p,0.01, and ###p,0.001, versus OVA i.p.
doi:10.1371/journal.pone.0071244.t002
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pathways, most noticeably Fabp5, in murine skin in response to
systemic and topical OVA sensitization.
Systemic Sensitization with OVA Increases Fabp5 Protein
Levels
Because Fabp5 gene expression in skin was induced after
repeated systemic OVA sensitization (Table 2), we next assessed
levels of Fabp5 protein in the skin of mice in our various
experimental conditions. Levels of Fabp5 protein as measured by
Western Blots, increased in skin of mice systemically sensitized
with OVA compared to controls (Figure 3a). However, highest
Fabp5 protein levels were detected in whole skin of mice
systemically treated with OVA (Figure 3a). In order to determine
the localization of Fabp5 across the skin, we performed
immunohistochemical analysis. We found intense staining for
Fabp5 in the thickened epidermis and around hair follicles of mice
treated with OVA (Figure 3b). Thus, systemic sensitization with
OVA is sufficient to increase levels of Fabp5 in the skin of mice.
Discussion
The present study demonstrates that the immune response in
allergen-induced dermatitis is associated with increased retinoid
signaling and RA concentrations in the skin. Moreover, signaling
via PPARd-mediated pathways, mostly through Fabp5 upregula-
tion, was mainly enhanced in allergen-induced dermatitis. Thus,
retinoid-mediated signaling is involved in the pathogenesis and/or
maintenance of allergic dermatitis or further atopic skin diseases
such as AD, but the exact pathway is not yet determined.
Figure 2. Serum levels of IL-4 and ATRA and the Fabp5 vs. Crabp2 ratio are increased in skin after OVA sensitizations. (a) IL-4 serum
levels after systemic with or without additional topical OVA sensitization (n = 8). (b) ATRA levels in mouse skin determined by HPLC MS-MS method
upon systemic (i.p.) and systemic plus topical (i.p.+e.c.) OVA sensitization (n = 3/group). (c) Ratio of Fabp5 vs. Crabp2 expression in the skin of OVA-
treated mice (n = 6/group) compared to control mice (PBS i.p.). Data are presented as mean values6 SEM. Statistical significance (p) is based on one-
way ANOVA followed by Tukey’s multiple comparison test for gene expression results and ELISA data. For HPLC MS-MS results, significance was
determined using Student’s t-test.
doi:10.1371/journal.pone.0071244.g002
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High RA levels in the skin, as observed in the present work,
might directly impact on systemic and local immune responses
[14,35–38]. In our mouse model of allergen-induced dermatitis,
we found a mixed Th1- and Th2-type immune response in the
skin and high numbers of infiltrating dermal macrophages,
dendritic cells and mast cells (Table 1 and 2). In contrast, mice
systemically treated with OVA exhibited only a partial phenotype
with lower inflammatory infiltrates and cytokine expression in the
skin. Interestingly, the highest levels of immune response-related
gene expression, inflammatory cell infiltrates and serum cytokines
correlated with increased expression of RA synthesizing enzymes
and ATRA levels in inflamed skin. Thus, these data suggest that
only overt allergen-induced dermatitis leads to an increased
ATRA concentration and altered RA signaling in the skin.
The increased ATRA levels in the skin of OVA-sensitized mice
(Figure 2b, Table S1) might reflect the induced expression of RA
synthesizing enzymes (Table 3) that in turn may result in elevated
ATRA synthesis in murine skin. However, besides resident skin
cells, infiltrating immune cells might be a source of ATRA in
sensitized skin. For example, human basophils which have been
shown to infiltrate AD skin [39] were found to express Aldh1a2
enzyme and to produce RA upon activation with IL-3 in an ex vivo
model [40]. However, identification of specific cell types produc-
ing RA in inflamed skin is currently not feasible due to problems in
acquiring sufficiently large numbers of highly purified cells from
the skin.
One of the major outcomes of the present work was to
demonstrate that systemic sensitization of mice per se is sufficient
to induce partial skin immune responses and an impairment of
expression of key genes involved in skin homeostasis and barrier
function (Table 1 and 2, Figure 2a). Previous studies and reviews
reported an ‘‘outside-inside-outside’’ pathogenic mechanism of
AD [4–6]. In contrast, our data support an ‘‘inside-out’’
Table 3. Systemic and topical OVA sensitizations induce retinoic acid synthesis and dysregulate retinoid-mediated signaling in
skin of mice.
Fold change
Gene name Symbol OVA i.p. OVA i.p.+e.c.
Retinal synthesis
Short chain dehydrogenase/reductase 16C5 Sdr16c5 1.760.2* 1.860.2*
Retinol dehydrogenase 10 Rdh10 1.160.1 1.360.1
Retinoic acid synthesis
Aldehyde dehydrogenase 1A1 Aldh1a1 1.860.2 2.460.4**
Aldehyde dehydrogenase 1A2 Aldh1a2 0.560 3.961.3*#
Aldehyde dehydrogenase 1A31 Aldh1a3 4.860.4** 4.060.8**
Retinoid receptors
Retinoic acid receptor a Rara 0.860.1 1.060.1
Retinoic acid receptor b1 Rarb 0.860.1 0.960.1
Retinoic acid receptor c Rarg 0.860.1 1.360.2#
Retinoid X receptor a Rxra 0.760.1 1.660.2*###
RAR target genes involved in retinoid signaling
Retinoic acid degradation
Cytochrome P450 26A1 Cyp26a1 2.160.7 7.962.2**#
Cytochrome P450 26B1 Cyp26b1 0.660.1 1.960.2*##
Retinoid transport proteins
Cellular retinol binding protein 1 Rbp1 3.560.2*** 3.060.2***
Cellular retinoic acid binding protein 2 Crabp2 1.360.1 1.460.1
Retinol esterification
Lecithin-retinol acyltransferase Lrat 2.460.3 2.560.7
Further RAR target genes not involved in retinoid signaling
Keratin 4 Krt4 0.660.2 0.360*
Retinoic acid receptor responder 2 Rarres2 0.560.1* 0.660.1
Transglutaminase 2 Tgm2 0.960.1 0.760.1
e.c., epicutaneous; i.p., intraperitoneal; OVA, ovalbumin.
1RAR target genes.
Fold change data are expressed as mean 6 SEM (n = 6) and were determined in skin specimen of sensitized mice by TLDA. Statistical significance (p) was tested using
one-way ANOVA followed by Tukey’s multiple comparison test.
*p,0.05,
**p,0.01,
***p,0.001, versus control (PBS i.p.);
#p,0.05,
##p,0.01, and ###p,0.001, versus OVA i.p.
doi:10.1371/journal.pone.0071244.t003
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mechanism significantly contributing to the development of overt
skin inflammation.
It has previously been shown that ATRA is not only ligand of
RARs but can also activate PPARd and induce PPARd target gene
expression. PPARd signaling is favored instead of RAR pathways
when the ratio of the lipid transporters Fabp5 vs. Crabp2 is high
within cells such as keratinocytes [19,20]. We determined highest
Fabp5 protein levels in the skin of mice treated systemically with
OVA (Figure 3a). In contrast, immunohistochemical analysis
showed particularly intense staining in the epidermis and around
hair follicles of mice with allergen-induced dermatitis (Figure 3b).
In the literature, Fabp5 protein is described to be predominantly
present in epidermis [41], sebaceous glands and hair follicles [42]
and in subcutaneous adipocytes [43]. However, in our study
western blot analysis was performed from whole skin, therefore, a
larger increase of Fabp5 protein expression in dermis and/or
subcutaneous fat after systemic OVA treatment compared to
systemic and topical treatment may explain the apparent
discrepancy between Figures 3a and 3b. Notably, in our mouse
model, the Fabp5 vs. Crabp2 ratio was increased in allergen-
induced dermatitis (Figure 2c). This data might suggest favored
ATRA signaling through PPARd which may significantly
contribute to the specific gene expression patterns observed in
this study (see below and indicated in Figure 3c). PPARd signaling
and several of its target genes were previously found increased in
psoriasis and lesional AD skin [18,33,44] and Romanowska et al.
[18] further demonstrated the induction of an inflammatory skin
disease similar to human psoriasis in PPARd-overexpressing mice.
Interestingly, in our mouse model of allergen-induced dermatitis
we observed an increased expression of several of the investigated
target genes involved in PPARd signaling pathways in skin.
Though further investigations potentially involving PPARd
knockout mice would be required to confirm these data, our
results suggest favored ATRA-mediated PPARd signaling in
allergen-induced dermatitis.
Most notably, several RAR target genes involved in retinoid
signaling were induced in allergen-induced dermatitis, whereas
expression of RAR targets which are not implicated in retinoid
signaling (Krt4, Rarres2, Tgm2) was not significantly altered.
Thus, expression of genes involved in RA synthesis as well as
degradation, transport and esterification, and especially of RAR
target genes was increased in allergen-induced dermatitis. In
contrast, expression of RAR target genes rather related to
epidermal differentiation remained unaltered or reduced. These
data thus indicate that potentially increased ATRA synthesis via
Aldh1a enzymes and elevated ATRA levels in mouse skin
observed in allergen-induced dermatitis might not result in an
overall increase of RAR-mediated signaling. Furthermore, OVA
treatment might also affect the level of several other lipids and
nuclear receptor agonists than ATRA in mouse skin.
In summary, allergen-induced dermatitis is associated with
increased retinoid signaling and elevated ATRA levels in the skin.
Because expression of genes involved in all aspects of RA
metabolism is increased, whereas expression of RAR target genes
involved in other pathways such as epidermal differentiation
remains largely unchanged, allergen-induced dermatitis might
additionally redirect intracellular retinoid flux and metabolism.
Moreover, PPARd gene targets were mainly induced indicating
Figure 3. Increased Fabp5 expression in allergen-induced dermatitis. (a) Fabp5 protein levels in the skin of mice with allergen-induced
dermatitis. 150 mg proteins were loaded per lane and beta-actin was used as control for even protein loading. (b) Immunohistochemical analysis of
Fabp5 protein expression in five-micrometer back skin sections of OVA-sensitized mice. (c) ATRA-induced nuclear receptor-mediated signaling
pathways depending on the predominant cellular transport protein.
doi:10.1371/journal.pone.0071244.g003
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that RAR-mediated signaling and certain pathways/molecules
involved in PPARd signaling are altered in allergic dermatitis skin.
Furthermore, systemic sensitization with an allergen is sufficient to
modify the expression of genes central to epidermal homeostasis
suggesting an ‘‘inside-out’’ effect of allergen in allergic skin disease
pathogenesis possibly by increasing allergen penetration through
the skin. Whether disturbed retinoid metabolism and retinoid-
mediated signaling are symptoms or potential initiators of atopic
sensitization still remains to be elucidated.
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